Johnson Chemical Pharmaceutical Works Co., Ltd.
Informe acción TPEX:4747
Capitalización de mercado: NT$3.3b
Johnson Chemical Pharmaceutical Works Dividendos y recompras
Dividendo controles de criterios 4/6 Johnson Chemical Pharmaceutical Works es una empresa que paga dividendos con una rentabilidad actual de 2.05% que está bien cubierta por los beneficios.
Información clave
2.1%
Rentabilidad por dividendo
-13.9%
Rendimiento de la recompra
Rendimiento total para el accionista -11.9% Rendimiento futuro de los dividendos n/a Crecimiento de los dividendos 0.6% Próxima fecha de pago de dividendos n/a Fecha ex dividendo n/a Dividendo por acción NT$1.500 Ratio de pago 83%
Últimas actualizaciones de dividendos y recompras
Upcoming dividend of NT$1.50 per share Jun 14
Upcoming dividend of NT$2.00 per share at 2.5% yield Jun 05
Upcoming dividend of NT$1.45 per share Jun 15
Upcoming dividend of NT$1.92 per share May 25
Mostrar todas las actualizaciones
Second quarter 2024 earnings released: EPS: NT$0.50 (vs NT$0.75 in 2Q 2023) Aug 15
Now 20% overvalued Aug 13
Upcoming dividend of NT$1.50 per share Jun 14
First quarter 2024 earnings released: EPS: NT$0.45 (vs NT$0.74 in 1Q 2023) May 19
Full year 2023 earnings released: EPS: NT$2.24 (vs NT$2.16 in FY 2022) Apr 02
New minor risk - Market cap size Mar 15
Johnson Chemical Pharmaceutical Works Co., Ltd., Annual General Meeting, May 24, 2024 Mar 08
Now 20% undervalued after recent price drop Feb 16
Now 20% undervalued after recent price drop Nov 23
Third quarter 2023 earnings released: EPS: NT$0.45 (vs NT$0.64 in 3Q 2022) Nov 18
New minor risk - Shareholder dilution Sep 10
Second quarter 2023 earnings released: EPS: NT$0.75 (vs NT$0.48 in 2Q 2022) Aug 12
New minor risk - Market cap size Jul 29
Investor sentiment improves as stock rises 26% Jun 19
Upcoming dividend of NT$2.00 per share at 2.5% yield Jun 05
Investor sentiment improves as stock rises 17% Jun 01
First quarter 2023 earnings released: EPS: NT$0.75 (vs NT$0.42 in 1Q 2022) May 17
Investor sentiment improves as stock rises 16% May 04
Full year 2022 earnings released: EPS: NT$2.16 (vs NT$1.64 in FY 2021) Mar 31
Investor sentiment improves as stock rises 19% Feb 06
Investor sentiment deteriorated over the past week Jan 03
Investor sentiment improved over the past week Dec 13
No independent directors Nov 16
Third quarter 2022 earnings released: EPS: NT$0.64 (vs NT$0.44 in 3Q 2021) Nov 13
Second quarter 2022 earnings released: EPS: NT$0.48 (vs NT$0.43 in 2Q 2021) Aug 18
Upcoming dividend of NT$1.45 per share Jun 15
First quarter 2022 earnings released: EPS: NT$0.42 (vs NT$0.35 in 1Q 2021) May 16
No independent directors Apr 27
Full year 2021 earnings released: EPS: NT$1.64 (vs NT$2.12 in FY 2020) Mar 31
Johnson Chemical Pharmaceutical Works Co., Ltd., Annual General Meeting, May 26, 2022 Mar 06
Third quarter 2021 earnings released: EPS NT$0.44 (vs NT$0.47 in 3Q 2020) Nov 13
Upcoming dividend of NT$1.92 per share May 25
First quarter 2021 earnings released: EPS NT$0.35 (vs NT$0.61 in 1Q 2020) May 17
Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat? Mar 25
Full year 2020 earnings released: EPS NT$2.12 (vs NT$2.15 in FY 2019) Mar 25
New 90-day high: NT$37.65 Mar 06
Johnson Chemical Pharmaceutical Works Co., Ltd., Annual General Meeting, May 17, 2021 Mar 03
These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well Feb 18
Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock Feb 01
New 90-day low: NT$36.80 Jan 13
Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Jan 12
Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock? Dec 25
Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide? Dec 07
Third quarter 2020 earnings released: EPS NT$0.47 Nov 14
New 90-day low - NT$37.55 Sep 10
New 90-day low - NT$38.10 Aug 20
First half earnings released Aug 16
New 90-day low - NT$39.00 Jul 17
Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: El pago de dividendos de 4747 ha sido volátil en los últimos 10 años.
Dividendo creciente: El pago de dividendos de 4747 ha aumentado en los últimos 10 años.
Rentabilidad por dividendo vs. Mercado Rentabilidad por dividendo de Johnson Chemical Pharmaceutical Works vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de 4747 con la del mercado? Segmento Rentabilidad por dividendo Empresa (4747) 2.1% Suelo de mercado 25% (TW) 1.7% Techo de mercado 25% (TW) 4.5% Media de la industria (Pharmaceuticals) 2.2% Analista de previsiones (4747) (hasta 3 años) n/a
Dividendo destacado: El dividendo de 4747(2.05%) es más alto que el 25% inferior de los pagadores de dividendos del mercado TW (1.71%).
Alto dividendo: El (2.05%) del dividendo de 4747 es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado TW (4.47%).
Pago de beneficios a los accionistas
Cobertura de los beneficios: Con su actual ratio de pago (82.9%), los pagos de 4747 están cubiertos por los beneficios.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: Con su actual ratio de pago en efectivo (77.8%), los pagos de dividendos de 4747 están cubiertos por los flujos de caja.
Descubre empresas que pagan buenos dividendos Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}